OptimizeRx Launches CopayCue Solution
Analysis based on 6 articles · First reported Jun 30, 2026 · Last updated Jun 30, 2026
The launch of CopayCue by OptimizeRx is expected to positively impact the healthcare technology and pharmaceutical industries by addressing medication affordability and improving patient adherence. This could lead to increased prescription volumes for life sciences companies and enhanced revenue for OptimizeRx.
OptimizeRx launched CopayCue, a new healthcare technology solution designed to integrate brand savings offers directly into the e-prescribing workflow. This enhancement to OptimizeRx's Financial Assistance solution utilizes real-time HCP prescribing intent data to deliver copay cards and affordability resources, aiming to increase transparency, remove cost barriers, and improve patient access to prescribed therapies. The company expects CopayCue to increase prescription lift by 4-5% over existing methods, addressing the significant issue of medication non-adherence due to cost, which is estimated to cost the U.S. health system $100-$300 billion annually. Louis Trivento and Steve Silvestro of OptimizeRx highlighted the solution's potential to strengthen campaign performance for life sciences brands and expand patient access.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard